Literature DB >> 20820991

Paraneoplastic neurological syndrome in a patient with gastric cancer.

Hitoshi Murakami1, Yasushi Rino, Shoji Yamanaka, Yasuhisa Baba, Takashi Sekiguchi, Norio Yukawa, Takashi Oshima, Nobuhiro Sugano, Hitoshi Matsuura, Munetaka Masuda, Toshio Imada.   

Abstract

Paraneoplastic neurological syndromes (PNSs) are a heterogeneous group of neurological disorders caused by immune-mediated mechanisms. The incidence of PNS is much less than 1% for solid tumors, except for small-cell lung cancer and thymoma. We report a rare case of gastric cancer that presented with primary clinical findings of PNS. The patient was a 63-year-old woman who was admitted for worsening neuropathy. Laboratory and neurological tests excluded a nutritional deficit, diabetes mellitus, and connective tissue disease as causes of her neuropathy. Computed tomography (CT) of the abdomen, positron emission tomography (PET)-CT, and endoscopy of the stomach revealed gastric cancer with lymph node swelling. Distal gastrectomy was performed and pathological and immunohistochemical examinations indicated endocrine cell carcinoma. The gastrectomy stopped the exacerbation of her symptoms and recurrence was not observed, but the neurological disorders were irreversible. This case suggests that early diagnosis of the primary tumor is required to improve the outcome in patients with PNS.

Entities:  

Mesh:

Year:  2010        PMID: 20820991     DOI: 10.1007/s10120-010-0563-2

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


  13 in total

1.  Favourable prognosis in Lambert-Eaton myasthenic syndrome and small-cell lung carcinoma.

Authors:  P Maddison; J Newsom-Davis; K R Mills; R L Souhami
Journal:  Lancet       Date:  1999-01-09       Impact factor: 79.321

2.  Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients.

Authors:  F Graus; F Keime-Guibert; R Reñe; B Benyahia; T Ribalta; C Ascaso; G Escaramis; J Y Delattre
Journal:  Brain       Date:  2001-06       Impact factor: 13.501

Review 3.  Paraneoplastic syndromes of the spinal cord, nerve, and muscle.

Authors:  S A Rudnicki; J Dalmau
Journal:  Muscle Nerve       Date:  2000-12       Impact factor: 3.217

4.  P/Q-type calcium channel antibodies, Lambert-Eaton myasthenic syndrome and survival in small cell lung cancer.

Authors:  Paul W Wirtz; Bethan Lang; Francesc Graus; Arn M J M van den Maagdenberg; Albert Saiz; Pia A de Koning Gans; Albert Twijnstra; Jan J G M Verschuuren
Journal:  J Neuroimmunol       Date:  2005-07       Impact factor: 3.478

5.  Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies.

Authors:  I Rojas; F Graus; F Keime-Guibert; R Reñé; J Y Delattre; J M Ramón; J Dalmau; J B Posner
Journal:  Neurology       Date:  2000-09-12       Impact factor: 9.910

6.  Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone.

Authors:  F Keime-Guibert; F Graus; A Fleury; R René; J Honnorat; P Broet; J Y Delattre
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-04       Impact factor: 10.154

7.  Recommended diagnostic criteria for paraneoplastic neurological syndromes.

Authors:  F Graus; J Y Delattre; J C Antoine; J Dalmau; B Giometto; W Grisold; J Honnorat; P Sillevis Smitt; Ch Vedeler; J J G M Verschuuren; A Vincent; R Voltz
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-08       Impact factor: 10.154

8.  Survival and outcome in 73 anti-Hu positive patients with paraneoplastic encephalomyelitis/sensory neuronopathy.

Authors:  Peter Sillevis Smitt; Joost Grefkens; Bertie de Leeuw; Martin van den Bent; Wim van Putten; Herbert Hooijkaas; Charles Vecht
Journal:  J Neurol       Date:  2002-06       Impact factor: 4.849

9.  FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes.

Authors:  S Younes-Mhenni; M F Janier; L Cinotti; J C Antoine; F Tronc; V Cottin; P J Ternamian; P Trouillas; J Honnorat
Journal:  Brain       Date:  2004-09-10       Impact factor: 13.501

10.  Current Therapies for Paraneoplastic Neurologic Syndromes.

Authors:  Myrna R. Rosenfeld; Josep Dalmau
Journal:  Curr Treat Options Neurol       Date:  2003-01       Impact factor: 3.598

View more
  3 in total

1.  Paraneoplastic neurological syndromes associated with gastric cancer: a case report and review of the literature.

Authors:  Takashi Taketa; Seiji Ohigashi; Koyu Suzuki; Kazuki Sudo; Hironori Shiozaki; Akihiro Suzuki; Mariela A Blum; Jaffer A Ajani; Hisashi Onodera
Journal:  Clin J Gastroenterol       Date:  2012-08-28

2.  Gastric cancer complicated by paraneoplastic neurological syndrome which presented with extremity numbness: a case report.

Authors:  Takuto Yoshida; Hideki Kawamura; Kazuhiro Mino; Yuji Konishi; Tomoya Saito; Yuichi Shimizu; Akinobu Taketomi
Journal:  Surg Case Rep       Date:  2022-04-28

3.  CV2/CRMP5-antibody-related Paraneoplastic Neurologic Syndrome Associated with Gastrointestinal Stromal Tumor.

Authors:  Hirofumi Fukushima; Tomoyoshi Shibuya; Takahito Awatsu; Taro Kurosawa; Keiichi Haga; Takashi Murakami; Nobuko Serizawa; Akio Mori; Mariko Hojo; Takashi Yao; Nobutaka Hattori; Akihito Nagahara
Journal:  Intern Med       Date:  2021-10-19       Impact factor: 1.282

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.